Immuron IMRN
NASDAQ IMRN
$1.22 +0.04 (+3.39%)
At close: Sep 18, 2026 · 4:00 PM EDT

Immuron (IMRN) Operating Income (2016 - 2025)

Immuron (IMRN) posted Operating Income of -$3.4 million for Q2 2025, down 8754.84% on a QoQ basis from -$38654.9 in Q3 2024, and up 10.47% year-over-year from -$3.1 million in Q2 2024.

Analysis

Immuron (IMRN) Operating Income (2016 - 2025) Analysis & Trends

Immuron has reported Operating Income for 10 years, with the latest figure at -$3.4 million in Q2 2025.

  • On a quarterly basis, Operating Income rose 10.47% year-over-year to -$3.4 million in Q2 2025; TTM through Jun 2025 was -$9.6 million, a 3.06% decrease from a year earlier, with the FY2026 full-year figure at -$4.0 million, down 7350.01% from the prior year.
  • Operating Income was -$3.4 million for Q2 2025 at Immuron, down from -$38654.9 in the prior quarter.
  • The five-year high for Operating Income was -$13326.4 in Q4 2021, with the low at -$6.5 million in Q2 2021.
  • Average Operating Income over 5 years is -$2.4 million, with a median of -$2.1 million recorded in 2023.
  • The sharpest annual moves came in 2021 and 2022: Operating Income soared 68.22% in 2021, then tumbled 14429.23% in 2022.
  • Over 5 years, Operating Income stood at -$13326.4 in 2021, then sank by 14429.23% to -$1.9 million in 2022, then slipped by 19.99% to -$2.3 million in 2023, then jumped by 98.34% to -$38654.9 in 2024, then plunged by 8754.84% to -$3.4 million in 2025.
  • The last three Operating Income figures came in at -$3.4 million (Q2 2025), -$38654.9 (Q3 2024), and -$3.8 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 3.51 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -10.39 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 1.25 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 1.29 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -815.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 493.00 Mn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 231.44 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -644.50 Mn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -365.99 Mn
10 Immuron 7.14 Mn -1.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.42 Mn
Sep 9, 2024 -38,654.88
Jun 30, 2024 -3.82 Mn
Dec 31, 2023 -2.32 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -1.94 Mn
Dec 31, 2021 -13,326.36
Jun 30, 2021 -6.45 Mn
Dec 31, 2020 -41,934.90
Jun 30, 2020 -1.90 Mn
Dec 31, 2019 -15,191.40
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.79 Mn
Dec 31, 2016 2.56 Mn
Jun 30, 2016 4.33 Mn